Cargando…

Liver and Muscle in Morbid Obesity: The Interplay of Fatty Liver and Insulin Resistance

INTRODUCTION: Nonalcoholic fatty liver disease (NAFLD) can be seen as a manifestation of overnutrition. The muscle is a central player in the adaptation to energy overload, and there is an association between fatty-muscle and -liver. We aimed to correlate muscle morphology, mitochondrial function an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Machado, Mariana Verdelho, Ferreira, Duarte M. S., Castro, Rui E., Silvestre, Ana Rita, Evangelista, Teresinha, Coutinho, João, Carepa, Fátima, Costa, Adília, Rodrigues, Cecília M. P., Cortez-Pinto, Helena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281005/ https://www.ncbi.nlm.nih.gov/pubmed/22359625 http://dx.doi.org/10.1371/journal.pone.0031738

Ejemplares similares

Fatty liver in lean patients: is it a different disease?
por: Verdelho Machado, Mariana, et al.
Publicado: (2012)

Aerobic Exercise in the Management of Metabolic Dysfunction Associated Fatty Liver Disease
por: Machado, Mariana Verdelho
Publicado: (2021)

Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet
por: Machado, Mariana Verdelho, et al.
Publicado: (2016)

Outcomes of excessive alcohol drinkers without baseline evidence of chronic liver disease after 15 years follow-up: Heavy burden of cancer and liver disease mortality
por: Bernardo, Sónia, et al.
Publicado: (2021)

A Bugs Battle on Behalf of the Liver
por: Machado, Mariana Verdelho
Publicado: (2016)

COVID-19 and pediatric fatty liver disease: Is there interplay?
por: Di Sessa, Anna, et al.
Publicado: (2021)

Hepcidin in morbidly obese women with non-alcoholic fatty liver disease
por: Auguet, Teresa, et al.
Publicado: (2017)

Expression of STING in Women with Morbid Obesity and Nonalcoholic Fatty Liver Disease
por: Bertran, Laia, et al.
Publicado: (2023)

Altered Fatty Acid Metabolism-Related Gene Expression in Liver from Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease
por: Auguet, Teresa, et al.
Publicado: (2014)

Psychotropic drugs and liver disease: A critical review of pharmacokinetics and liver toxicity
por: Telles-Correia, Diogo, et al.
Publicado: (2017)

PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease
por: Aragonès, Gemma, et al.
Publicado: (2016)

Alarming increase of NASH as cause of liver cancer
por: Craciun, Ana, et al.
Publicado: (2022)

Interplay of Lymphocytes with the Intestinal Microbiota in Children with Nonalcoholic Fatty Liver Disease
por: Liang, Tian, et al.
Publicado: (2022)

The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease
por: Finney, Alexandra C., et al.
Publicado: (2023)

Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive Review
por: Odriozola, Aitor, et al.
Publicado: (2023)

Endocannabinoid Receptors Gene Expression in Morbidly Obese Women with Nonalcoholic Fatty Liver Disease
por: Auguet, Teresa, et al.
Publicado: (2014)

Performance of Noninvasive Liver Fibrosis Tests in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease
por: Alqahtani, Saleh A., et al.
Publicado: (2021)

Thyroid Function and the Risk of Non-Alcoholic Fatty Liver Disease in Morbid Obesity
por: Borges-Canha, Marta, et al.
Publicado: (2020)

New Developments in Celiac Disease Treatment
por: Machado, Mariana Verdelho
Publicado: (2023)

Some Observations on the Effects of Cholagogue Medicines, and Some Remarks on Morbid Changes in the Liver. Fatty Liver; Lardaceous Liver; Cirrhosis; Jaundice
por: Jones, C. Handfield
Publicado: (1853)

The interplay of microRNAs and transcription factors in autophagy regulation in nonalcoholic fatty liver disease
por: Kim, Yumi, et al.
Publicado: (2021)

Clinical and genetic determinants of the fatty liver–coagulation balance interplay in individuals with metabolic dysfunction
por: Valenti, Luca, et al.
Publicado: (2022)

Metabolism of cyclic GMP in non-alcoholic fatty liver disease in morbid obesity
por: Urios, Amparo, et al.
Publicado: (2011)

Predictors for advanced fibrosis in morbidly obese non-alcoholic fatty liver patients
por: Zelber-Sagi, Shira, et al.
Publicado: (2017)

Increased Circulating Levels of Alpha-Ketoglutarate in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease
por: Aragonès, Gemma, et al.
Publicado: (2016)

Benign inheritable disorders of bilirubin metabolism manifested by conjugated hyperbilirubinemia–A narrative review
por: Morais, Mariana B., et al.
Publicado: (2022)

European ‘NAFLD Preparedness Index’ — Is Europe ready to meet the challenge of fatty liver disease?
por: Lazarus, Jeffrey V., et al.
Publicado: (2021)

Quality of life following liver transplantation: a comparative study between Familial Amyloid Neuropathy and liver disease patients
por: Telles-Correia, Diogo, et al.
Publicado: (2009)

The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic Background
por: Yu, Jinsheng, et al.
Publicado: (2016)

Role of Hedgehog Signaling Pathway in NASH
por: Verdelho Machado, Mariana, et al.
Publicado: (2016)

The Impact of Vitamin D in Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study in Patients with Morbid Obesity
por: Borges-Canha, Marta, et al.
Publicado: (2021)

Hepatic SPARC Expression Is Associated with Inflammasome Activation during the Progression of Non-Alcoholic Fatty Liver Disease in Both Mice and Morbidly Obese Patients
por: Onorato, Agostina M., et al.
Publicado: (2023)

MON-592 The Impact of Bariatric Surgery on the Risk of Non-Alcoholic Fatty Liver Disease in Morbidly Obese Patients
por: Borges-Canha, Marta, et al.
Publicado: (2020)

Shifting perspectives – interplay between non-alcoholic fatty liver disease and insulin resistance in lean individuals
por: Bilic-Curcic, Ines, et al.
Publicado: (2021)

Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis
por: Yang, Bing, et al.
Publicado: (2022)

Current insights into the interplay between gut microbiota-derived metabolites and metabolic-associated fatty liver disease
por: Dongoran, Rachmad Anres, et al.
Publicado: (2023)

Is Fatty Liver Associated with Increased Mortality and Morbidity in Coronavirus Disease 2019 (COVID-19) Pneumonia?
por: Madan, Kaushal, et al.
Publicado: (2022)

Risk of Obstructive Sleep Apnea with Daytime Sleepiness Is Associated with Liver Damage in Non-Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease
por: Pulixi, Edoardo Alessandro, et al.
Publicado: (2014)

Effect of silymarin on liver size and nonalcoholic fatty liver disease in morbidly obese patients: A randomized double-blind clinical trial
por: Atarodi, Hamed, et al.
Publicado: (2022)

Nonalcoholic fatty liver disease in adolescents with phenylketonuria
por: Silveira, Adriana Márcia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n5903stff0co23osn7ighirfrf